06/13/2026
Psilomethoxin, a compound structurally bridging psilocin and 5-MeO-DMT, was synthesized in 1965 but never tested in humans. It remained forgotten for decades, yet its therapeutic potential for depression and PTSD, alongside its effects on the default mode network, is now being explored.